PPT-Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Author : grace3 | Published Date : 2022-06-15
Christine Lauro MD Radiation Oncologist April 21 2018 Outline Epidemiology Breast Cancer Risk FactorsSymptoms Benefits of Screening Review of Guidelines Epidemiology
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Breast Cancer Guideline Update – Sharp..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk: Transcript
Christine Lauro MD Radiation Oncologist April 21 2018 Outline Epidemiology Breast Cancer Risk FactorsSymptoms Benefits of Screening Review of Guidelines Epidemiology Epidemiology The chance of developing an invasive breast cancer at some time in a womans life is about 1 in 8 12. Kristin . DePrince. Mattie, M.S.. Licensed / Certified Genetic Counselor. William G. Rohrer Cancer Genetics Program. Objectives. Describe . current approaches to genetic testing for hereditary cancer syndromes. Generosa. . Grana. , MD. Professor, Cooper Medical School of Rowan University. Director, MD Anderson Cancer Center at Cooper. Overview. Factors that affect breast cancer risk. Tools to assess risk. Role of genetics in this process. For Fellows November 2016. American Cancer Society, 2015 Statistics. Risk Factors. Female. Age: median 57-62. Family history. Previous biopsies. Atypical changes. BRCA positive. Hormone replacement. Alcohol use. October 25,2017. Disclosures. None. Outline. Epidemiology. Risk Factors. Screening. Diagnosis. Treatment. Genetic testing. Research. Epidemiology. 2017 :estimated 252.710 new cases of invasive breast cancer in women. Rachna Raman MD MS. Hematology and Medical Oncology. Bon Secours Cancer Institute at St. Mary’s Hospital. Objectives. Risk factors . Screening guidelines and controversies. Screening and management of patients at high risk for breast cancer. Caribbean Hematology Oncology Center. Cancer statistics, 2018. Cancer statistics, 2018, Volume: 68, Issue: 1, Pages: 7-30, First published: 04 January 2018, DOI: (10.3322/caac.21442) . Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. c. ancer . e. tiology. Elisa V. Bandera, MD, PhD. Associate Professor of Medicine. The Cancer Institute of New Jersey. Robert Wood Johnson Medical School. Possible reasons for poorer survival in African Americans. Edmund Tai, MD. Hematology/Oncology. PAMF. American Cancer Society Cancer Prevention . Study-II. Harvard . Nurses' Health Study (NHS. ). Hawaii-Los . Angeles Multiethnic . Cohort. Prostate. , Lung, Colorectal and Ovarian Cancer . Steven J. Katz MD MPH. Professor of Medicine and Health Management and Policy. University of Michigan . Allison Kurian MD M Sc.. Professor of Medicine and Medical Genetics . Stanford University . Guidelines 2019. Audience. : . GenEd. Biology . students. Linda Grisham, Massachusetts Bay Community College. Mark Maloney, Spelman College. Kim . Gernert. , Emory University . Inspired by the recent Angelina Jolie health . Rajiv Doddamani. . PGY – 3, Internal Medicine . . St. Joseph Mercy Ann Arbor . Learning objectives . Explain the principles of breast cancer screenings . group. of diseases. . All forms of cancer cause cells in the body to change and grow out of control. . Most types of cancer cells form a lump or mass called a . tumor. . . The tumor can invade and destroy healthy tissue. Cells from the tumor can break away and travel to other parts of the body. There they can continue to grow. . Notes from meeting: February 21, 2023. GOALS. Improve collaboration and documentation towards assessment and recommendations related to genetic and genomic testing in young women with breast cancer. Offer recommendations to improve value and service for the ACBCYW . Azeez Farooki, MD. Attending Physician, Clinical Member. Memorial Sloan Kettering Cancer Center. New York, NY. Objectives. Elucidate the problem of aromatase inhibitor induced bone loss and increased risk of fractures in breast cancer.
Download Document
Here is the link to download the presentation.
"Breast Cancer Guideline Update – Sharp Focus on Who is at Risk"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents